Clinical Trials Logo

Locally Advanced Cervical Cancer clinical trials

View clinical trials related to Locally Advanced Cervical Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03612791 Active, not recruiting - Clinical trials for Locally Advanced Cervical Cancer

Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab

ATEZOLACC
Start date: August 13, 2018
Phase: Phase 2
Study type: Interventional

The primary objective of this randomized phase II trial is to evaluate the clinical benefits of the addition of atezolizumab to standard chemoradiotherapy (CRT) (first given concurrently with CRT, then continued as adjuvant treatment), compared with CRT alone, on investigator-assessed progression-free survival (PFS), as per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1).

NCT ID: NCT01793701 Active, not recruiting - Clinical trials for Locally Advanced Cervical Cancer

Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer

DEPICT
Start date: July 2010
Phase: Phase 1/Phase 2
Study type: Interventional

This will be the first study to assess the clinical feasibility of dose escalation with simultaneous integrated boost intensity-modulated radiotherapy for patients with locally advanced cervical cancer. Following screening to confirm eligibility patients will commence a six week treatment period. After this, patients will be followed up by visits to clinic every 3 months for a period of 24 months (2 years). End of study is defined as 24 months after treatment. Patients will be followed up for a minimum of 5 years (as per local policy) after treatment.